epcoritamab
genmab,abbvie
['toci', 'bet', 'dlbcl', 'cll', 'epcoritamab', 'fil,veral,12', 'epcore,nhl,1', 'elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'leukemia', '2019', 'nhl', '2018', 'lymphoma', 'tocilizumab', 'epcore,nhl,2', 'lymsm']
study schema and rationale for epcoritamab in richter's transformation of cll #ash22 #lymsm 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer